Market revenue in 2021 | USD 692.5 million |
Market revenue in 2030 | USD 1,551.2 million |
Growth rate | 9.4% (CAGR from 2021 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Preclinical |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preclinical, Clinical |
Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 66.14% in 2021. Horizon Databook has segmented the U.S. large molecule bioanalytical testing services market based on preclinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
This growth can be attributed to rapid increase in development of biologics to meet the growing demand for efficient healthcare in the country and strong R&D & promotion of new therapies. High healthcare expenditure in the country will also augment market growth.
Growing investment in pharmaceutical R&D coupled with rising number of clinical trials will also boost the U.S. large molecule bioanalytical testing market. For instance, the U.S. conducted 134,516 clinical trials between 1999 and 2019, as registered on WHO’s International Clinical Trials Registry Platform (ICTRP).
Robust product pipeline in the pharmaceutical and biopharmaceutical industry will also augment market growth for large molecule bioanalytical testing in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. large molecule bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into U.S. large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account